SHANGHAI, CHINA -- (MARKET WIRE) -- May 23, 2007 -- SinoBiomed Inc. is pleased to announce that its 82% owned subsidiary, Shanghai Wanxing Bio-pharmaceuticals Co., Ltd., has signed a letter of intent with the equity owners of Suzhou Baoi Medical Development Company to acquire their company.
